Philippe Lefran莽ois
Dr. Lefran莽ois is the Director of Research in the Division of Dermatology at 91黑料网. He is an Assistant Professor of Medicine, of Pharmacology & Therapeutics, and of Surgery. He is a full-time staff dermatologist at the Jewish General Hospital where he is actively involved in multidisciplinary skin cancer clinics and tumor boards. He is an investigator at the Lady Davis Institute where he established a broad skin cancer biobank and a skin cancer translational genomics laboratory. He leads the Terry Fox Research Institute 鈥� Marathon of Hope Cancer Centre Network initiatives on BCC and SCC. He is a member of the R茅seau Recherche Cancer 鈥� Qu茅bec, and Qu茅bec Cancer Consortium. He co-chairs SkIN Canada鈥檚 Translational Research Committee. His research program is supported by the JGH Foundation, LDI, TFRI-MOHCCN, FRQS, Cancer Research Society, Canadian Dermatology Foundation/CIHR, Canadian Foundation for Innovation, Montreal Dermatology Research Institute, and CQDM. His translational activities include collaborations with biotechs to bring novel cancer therapeutics and diagnostics to pre-clinical and phase I studies. Dr. Lefran莽ois holds a Ph.D. from Yale University, and a M.D. from Universit茅 de Montr茅al. He completed his dermatology residency at 91黑料网. His work on skin cancers has been recognized by the CDA and the AAD.聽